1. Home
  2. KRNT vs ANIP Comparison

KRNT vs ANIP Comparison

Compare KRNT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNT
  • ANIP
  • Stock Information
  • Founded
  • KRNT 2002
  • ANIP 2001
  • Country
  • KRNT Israel
  • ANIP United States
  • Employees
  • KRNT N/A
  • ANIP N/A
  • Industry
  • KRNT Industrial Machinery/Components
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRNT Industrials
  • ANIP Health Care
  • Exchange
  • KRNT Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • KRNT 1.4B
  • ANIP 1.2B
  • IPO Year
  • KRNT 2015
  • ANIP N/A
  • Fundamental
  • Price
  • KRNT $21.36
  • ANIP $60.62
  • Analyst Decision
  • KRNT Strong Buy
  • ANIP Buy
  • Analyst Count
  • KRNT 5
  • ANIP 7
  • Target Price
  • KRNT $34.00
  • ANIP $78.83
  • AVG Volume (30 Days)
  • KRNT 360.8K
  • ANIP 274.3K
  • Earning Date
  • KRNT 02-12-2025
  • ANIP 02-28-2025
  • Dividend Yield
  • KRNT N/A
  • ANIP N/A
  • EPS Growth
  • KRNT N/A
  • ANIP N/A
  • EPS
  • KRNT N/A
  • ANIP N/A
  • Revenue
  • KRNT $203,825,000.00
  • ANIP $614,376,000.00
  • Revenue This Year
  • KRNT $11.22
  • ANIP $26.80
  • Revenue Next Year
  • KRNT $12.76
  • ANIP $6.89
  • P/E Ratio
  • KRNT N/A
  • ANIP N/A
  • Revenue Growth
  • KRNT N/A
  • ANIP 26.20
  • 52 Week Low
  • KRNT $13.59
  • ANIP $52.50
  • 52 Week High
  • KRNT $34.29
  • ANIP $70.81
  • Technical
  • Relative Strength Index (RSI)
  • KRNT 16.62
  • ANIP 56.41
  • Support Level
  • KRNT $22.29
  • ANIP $57.88
  • Resistance Level
  • KRNT $23.88
  • ANIP $62.62
  • Average True Range (ATR)
  • KRNT 1.24
  • ANIP 2.67
  • MACD
  • KRNT -0.32
  • ANIP 0.29
  • Stochastic Oscillator
  • KRNT 3.66
  • ANIP 75.29

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: